Olon Spa, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is GLIPIZIDE, with a corresponding US DMF Number 29321.
Remarkably, this DMF maintains an Active status since its submission on April 22, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 07, 2016, and payment made on September 09, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II